beth israel deaconess medical center a harvard medical school teaching hospital

To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
Smaller Larger

Breast Cancer Care

The National Accreditation Program for Breast Centers (NAPBC), a part of the Commission on Cancer of the American College of Surgeons - sets national standards for Breast Care Centers. This independent organization evaluates the quality of care in breast programs by looking at key quality measures and only awards certification if these standards are met. The Breast Care Center at BIDMC has received full, three-year accreditation by the National Accreditation Program for Breast Centers, and is the first breast center at a Boston academic medical center to achieve this status.

BIDMC also participates in the Commission on Cancer's efforts to monitor the quality of cancer care in partnership with the National Quality Forum.

Breast Cancer Care: 

Each year over 500 patients are treated for breast cancer at BIDMC. Presented below is BIDMC's performance on key quality measures, compared to national performance benchmarks.

For more information about each measure and its benchmark, click on the name of the measure.

Access to Care & Patient Experience

Access to Care BIDMC
Performance1
Q1 FY 14
 BIDMC Goal 1
Q1 FY 14
% Of new patients seen in the Breast Center within 14 days of their request for a non-urgent care appointment
A higher score is better.
61% 75%

1 BIDMC Performance data is from Administrative Databases. BIDMC Goal reflects Breast Care Center desired performance.

Patient Experience 
(A higher score is better)
BIDMC
Performance
Q1 FY 14

Custom Comparative Massachusetts2
Q1 FY 14

National Database2
Q1 FY 14
Overall Visit Experience  91.7% 90.9% 90.9%
Experience with Care Provider 94.0% 93.6% 93.3%
Sensitivity to Personal Needs & Concerns 93.3% 92.5% 92.3%
Care Providers Efforts to Include Patients in Care Decisions 93.5% 93.4% 93.0%
Likelihood to Recommend BIDMC for Outpatient Breast Cancer Care 93.5% 93.4% 93.4

 2 Source of comparison data: Press Ganey Custom Comparative Database and Press Ganey National Participants.

Performance on Recommended Guidelines for Breast Cancer Care

National Accreditation Program for Breast Centers Performance Measures BIDMC Performance
CY 2011 3

BIDMC 
Performance
CY 2012 3

NAPBC
Benchmark4
Breast Conservation Rate (Stages 0-2) 
A higher score is better.
72% 71% 50%
Needle Biopsy Rate
(Palpation or Image guided)
 
A higher score is better.
100% 100% 100%
Clinical Trial Accrual Rate
(All eligible breast cancer patients)
A higher score is better.
13% 20% >2%

3 Source of BIDMC data is BIDMC Tumor Registry
4 Source of benchmark data is the National Accreditation Program for Breast Centers, Accreditation Standards Goal Performance.
National Quality Forum Measures for Breast Cancer Care 5 BIDMC Performance
CY 2011 3

National Avg for Teaching Hospitals Cancer Programs

National
Performance for All Approved Commission on Cancer Programs
Radiation therapy is administered within 1 year of diagnosis for women under age 70 who are receiving breast conserving surgery for breast cancer
A higher score is better.
91.0% 92.2% 92.1%
Combination chemotherapy is considered or administered within 4 months of diagnosis for women under age 70 with Stage 2 or 3 Hormone Receptor Negative (HR-) breast cancer
A higher score is better.
87.0% 91.6% 92.6%
Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year of diagnosis for women with Stage 2 or 3 Hormone Receptor Positive (HR+) breast cancer
A higher score is better.
96.6% 90.1% 90.0%

3 Source of BIDMC data is BIDMC Tumor Registry
5 BIDMC and National Average performance for Teaching Hospital Cancer Programs benchmark performance data provided by the NCDB and the American College of Surgeons, Cancer program Practice Profile report (CP3R)©. For Breast Cancers, 2009-2011 Diagnoses.  Information provided with permission.

Breast Cancer Outcomes: 5-year Survival Rates

For Breast Cancer Patients initially diagnosed between 2003-2006, survival through 2011 (by Cancer Stage at time of diagnosis.).  Learn more about 5-year Observed Survival Rates. 

5-Year Observed Survival Rates by Stage 6 BIDMC Performance 6 National Performance for All Approved Commission on Cancer Programs 6
Stage 0 98.1% 95.6%
Stage 1 96.3% 92.2%
Stage 2 93.2% 85.4%
Stage 3 81.6% 66.7%
Stage 4 22.6% 21.1%

6 BIDMC Performance, and National Performance for All Approved Commission on Cancer Programs provided by the NCDB and the American College of Surgeons. Information provided with permission. 

Last Updated: February 2014

Contact Information

Silverman Institute for Health Care Quality and Safety
Beth Israel Deaconess Medical Center
330 Brookline Ave
Boston, MA 02215
617-667-1325